EODData

OTCBB, INNMF: Amplia Therapeutics Ltd

20 Jan 2026
LAST:

0.0645

CHANGE:
 0.04
OPEN:
0.0645
HIGH:
0.1050
ASK:
0.0000
VOLUME:
61.6K
CHG(%):
38.57
PREV:
0.1050
LOW:
0.0645
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
20 Jan 260.06450.10500.06450.064561.6K
15 Jan 260.10500.10500.10500.105050.0K
13 Jan 260.09520.09520.09520.0952500
08 Jan 260.12000.12000.12000.120020.0K
07 Jan 260.11500.11500.11500.115010.0K
06 Jan 260.11000.11000.10980.11005.1K
05 Jan 260.12000.12370.12000.123720.0K

PROFILE

Name:Amplia Therapeutics Ltd
About:Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in 1b/2a clinical trial for pancreatic cancer; and treatment of idiopathic pulmonary fibrosis, as well as ovarian cancer. It also develops AMP886 for application in oncology and chronic fibrosis indications. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:90 William Street, Melbourne, VIC, Australia, 3000
Website:https://www.ampliatx.com
FIGI:BBG00BNJ9570

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:0.1054.9%
MA10:0.1058.1%
MA20:0.0943.1%
MA50:0.1060.0%
MA100:0.1174.1%
STO14:14.33 
RSI14:45.63
WPR14:-85.67 
MTM14:-0.02
ROC14:-0.20 
ATR:0.02 
Week High:0.1162.8%
Week Low:0.060.0%
Month High:0.1291.8%
Month Low:0.06
Volatility:364.56